tirosin chinasi citoplasmatiche
DESCRIPTION
TIROSIN CHINASI CITOPLASMATICHE. TIROSIN CHINASI CITOPLASMATICHE. Tec (Btk/Itk/Bmx). PH. SH3. KINASE DOMAIN. SH2. FAK/Pyk2. KINASE DOMAIN. SH2. KINASE DOMAIN. KINASE DOMAIN. Jak. SH3. SH2. KINASE DOMAIN. SH2. SH2. KINASE DOMAIN. ZAP70/Syk. SH3. SH2. KINASE DOMAIN. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/1.jpg)
TIROSIN CHINASI CITOPLASMATICHE
![Page 2: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/2.jpg)
SH3 SH2 KINASE DOMAINPH Tec (Btk/Itk/Bmx)
KINASE DOMAIN FAK/Pyk2
KINASE DOMAIN KINASE DOMAINSH2 Jak
Src (Blk, Lck, Lyn, Fyn, Fgr, Hck, Yes)
KINASE DOMAINSH2 SH2 ZAP70/Syk
(FERM) Focal adhesion targeting (paxillin binding)
TIROSIN CHINASI CITOPLASMATICHE
Abl/Arg
KINASE DOMAINSH3 SH2
KINASE DOMAINSH3 SH2
Ac. miristico/palmitico
Ac. miristico
![Page 3: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/3.jpg)
![Page 4: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/4.jpg)
G. Steven Martin : THE HUNTING OF THE SRC, Nature Reviews Molecular Cell Biology 2, 467-475 (2001)
![Page 5: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/5.jpg)
![Page 6: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/6.jpg)
![Page 7: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/7.jpg)
Src
Integrine
![Page 8: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/8.jpg)
FAKYP397
SH2
SH3
Src
FAK e membri della famiglia del Src costituiscono un’unità di trasduzione del segnale da partedi molecole adesive definite INTEGRINE
FAK
SH2
SH3
SrcSH1
SH1
![Page 9: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/9.jpg)
Outside-in signaling
![Page 10: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/10.jpg)
FAK
Interazione con catena delle integrine e fattori di crescitaInterazione con fosfatidil inositolo (4,5) bisfosfato (PIP2)Interazione con proteine favorenti la polimerizzazione dell’actina (complesso Arp 2/3)
Interazione con paxillina
Cdominio cataliticodominio FERM dominio FATN
YP
AutofosforilazioneInterazioni con altre proteine(Src, PI3 chinasi, PLC
SH2YP
Sito di interazione con Grb2
SH2
Poli-P
Interazione con Cas
SH3
F1F1 F2F2 F3F3
![Page 11: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/11.jpg)
Anche FAK come Src viene attivata in seguito alla rottura di interazioni intermolecolari chela mantengono in uno stato inibito.
Anche FAK come Src viene attivata in seguito alla rottura di interazioni intermolecolari chela mantengono in uno stato inibito.
![Page 12: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/12.jpg)
![Page 13: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/13.jpg)
FAKYP397
SH2
SH3
Src
PYPI3KAKT
PROLIFERAZIONE ESOPRAVVIVENZA
Il distacco da proteine della matrice extracellulare induce una forma di apoptosi (chiamata “anoikis”)che determina il fenomeno della cosiddetta “crescita dipendente dall’ancoraggio”
![Page 14: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/14.jpg)
FAKYP397
SH2
SH3
SH1
Src
YP925
Grb2 Poli-P
Sos
Ras
RafMAPK
MAPK (ERK1/2)
TRASCRIZIONE GENICAProliferazione e sopravvivenza cellulare
CasPYPYPYCrkPoli-P
Dock180
Rac
PAK
JNKPolimerizzazione dell ’actinae protrusione del lamellopodio
Movimento cellulare
PI3-chinasi
P P P PPP
Fosfatidilinositolo 3,4,5 fosfato
PH
GEFs
Rac, Cdc42
PIP5-chinasi
Fosfatidilinositolo 4,5 fosfato
P PP
P
PLCIP3
paxillina
Interazione con altreProteine cito-scheletriche e segna-lanti
![Page 15: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/15.jpg)
FAK, Src e altre chinasi vengono inibite da tirosin fosfatasi che sono sensibili all’azione inibitoria di ROIs
Protein fosfatasiattiva
Protein fosfatasiinattiva
FAK, Src, GF-Rs, MAP chinasi (JNK, ERKs)
attive
FAK, Src, GF-Rs, MAP chinasi (JNK, ERKs)
inattive
![Page 16: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/16.jpg)
La transizione epitelio-mesenchimale rappresenta una modificazione tipica dei tumori epitelialimetastatici
An epithelial-mesenchymal transition (EMT) is a biologic process that allows a polarized epithelial cell, which normally interacts with basement membrane via its basal surface, to undergo multiple biochemical changes that enable it to assume a mesenchymal cell phenotype, which includes enhanced migratory capacity, invasiveness, elevated resistance to apoptosis, and greatly increased production of ECM components . The completion of an EMT is signaled by the degradation of underlying basement membrane and the formation of a mesenchymal cell that can migrate away from the epithelial layer in which it originated. (Kalluri and Weinberg, J. Clin. Invest. 119:1420, 2009)
![Page 17: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/17.jpg)
EPITHELIAL-MESENCHIMAL TRANSITION
MESENCHIMAL-EPITHELIAL TRANSITION
![Page 18: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/18.jpg)
![Page 19: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/19.jpg)
giunzioni serrate (tight junction)
giunzioni aderenti (adherens junctions)
E-caderina
cat.
p120 cat.
F-actina
F-actinavin
culina
p120 cat.
microtubuli
cat.
Rac
Rho
Movimento
Previene endocitosi e de-gradazione E- caderina
Migrazione nel nucleo e trascrizione geni implicati nella proliferazione cellulare
E-caderina
![Page 20: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/20.jpg)
giunzioni serrate (tight junction)
giunzioni aderenti (adherens junctions)
cat.
cat.
p120 cat.
F-actina
F-actinavin
culinaE-caderina
Recettori per fattori di crescita:TGFRI e II, IGF-1R, EGFR, c-Met
L’aumentata stimolazione con fattori di crescita altera funzioni di E-caderineIn diversi modi
![Page 21: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/21.jpg)
L’aumentata stimolazione con fattori di crescita altera funzioni di E-caderineIn diversi modi
1. Il promotore del gene per le E-caderine viene represso da repressori trascrizionali (Snail, Twist, Slug e altri) indotti da Recettori per GF e altre vie attivate nel corso di “progressione” tumorale (compreso Nf-B).
2. Tirosin chinasi recettoriali (EGFR, IGF-1R, c-Met, FGF) e non recettoriali (c-Src) inducono fosforilazione e successiva ubiquitinilazione di E-caderine e catenina con conseguente degradazione nel proteosoma. La fosforilazione di E-caderina comporta anche il distacco di e catenine.
3. Proteasi (metallo-proteasi – MMP) proteolizzano E-caderine alterando contatti cellula-cellula.
4. Gli stessi segnali che “down-regolano” espressione di E-caderine aumentano espressione di N-caderine (il cosiddetto “caderin-switch”), che sono espresse da cellule mesenchimali e regolano positivamente il movimento cellulare.
![Page 22: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/22.jpg)
cat. cat.
p120 cat.
F-actina
vincul
ina
E-caderina
Rac Cdc42 Rho
movimentoSress fibers, focal adhesion
![Page 23: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/23.jpg)
E-caderina
cat.PP P
DEGRADAZIONE
NUCLEO
Trascrizione geni implicati in proliferazione e progressione
GSK-3
SnailP
P
cat.
Repressione sintesi E-caderine
Inibizione di GSK da parte di GF-Rs o altri stimoli favorisce la progressione neoplastica
![Page 24: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/24.jpg)
Un meccanismo aggiuntivo di regolazione della funzione di catenica è rappresentato da un suo aumento diespressione in cellule stimolate con proteine wnt (ampia famiglia di fattori di crescita poco caratterizzati)
Gene onco-soppressore, la cuimutazione in cellule della linea germinale determina laPoliposi Adenomatosa Famigliaredel Colon
![Page 25: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/25.jpg)
a | In the absence of WNT signalling, -catenin levels in the cytoplasm and nucleus are low as a result of continuous phosphorylation by the serine/threonine kinases CK1 (casein kinase 1) and GSK3 (glycogen synthase kinase 3), leading to binding of -transducin-repeat-containing protein (TRCP) and to ubiquitylation and degradation by the proteasome. The destruction complex is composed of CK1 and GSK3, as well as the anchor proteins AXIN1 (axis inhibition protein 1 ) and APC (adenomatous polyposis coli). In the nucleus, TCF (T-cell factor) molecules are bound by co-repressors such as GRG/TLE (Groucho/transducin-like enhancer) proteins that shut off expression of WNT target genes. Other components of the repressor complex include CTbP (C-terminal binding protein) and HDACs (histone deacetylases). -catenin in the nucleus is inhibited from binding TCF by ICAT (cell autonomous inhibitor of -catenin and TCF) . The Frizzled receptor complex — composed of Frizzled and LRP5 (LDL-receptor-related protein 5) or LRP6 — can also be actively inhibited by receptor-bound soluble inhibitors such as DKK1 (Dickkopf homologue 1). b | Upon binding of a lipid-modified WNT protein to the receptor complex, a signalling cascade is initiated. LRP is phosphorylated by CK1 and GSK3, and AXIN1 is recruited to the plasma membrane. The kinases in the -catenin destruction complex are inactivated and -catenin translocates to the nucleus to form an active transcription factor complex with TCF, leading to transcription of a large set of target genes. In the nucleus, -catenin binds to TCF and LEF factors and recruits co-factors such as legless (LGS; also known as BCL9) and Pygopus (PYGO), CBP/p300, Brahma and MED12 to initiate transcription99, 100, 101. DVL, mammalian homologue of Drosophila Dishevelled; PP2A, protein phosphatase 2A.
![Page 26: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/26.jpg)
![Page 27: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/27.jpg)
![Page 28: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/28.jpg)
Dipartimento di PatologiaSezione di Patologia Generale
Università di Verona
![Page 29: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/29.jpg)
R. Ren, 5:172-183
Haematopoietic stem cell
Common myeloid progenitors
Chronic myeloid leukemia-chronic phase
Granulocyte/macrophage progenitors
Megakaryocyte/erythrocyte progenitors
Common lymphoid progenitorsChronic myeloid leukemia-blast phase (70%)
Chronic myeloid leukemia-blast phase(30%)
![Page 30: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/30.jpg)
With the aid of several mediator proteins, BCR-ABL associates with Ras and stimulates its activation. The adaptor protein, growth factor receptor-bound protein 2 (GRB2), interacts with BCR-ABL through the proximal SRC homology 2 (SH2)-binding site that develops when the tyrosine 177 (Y177) residue of BCR-ABL is autophosphorylated. GRB2, when bound to BCR-ABL, interacts with the son of sevenless (SOS) protein. The resulting BCR–ABL–GRB2–SOS protein complex activates Ras. The adaptor proteins CRKL (CRK-like) and SHC (SH2-containing protein) can also mediate the BCR-ABL activation of Ras. Ras and the mitogen activated protein kinase (MAPK) pathway are coupled by Raf (a serine/threonine kinase). Raf catalyses the phosphorylation of the mitogen-activated and extracellular-signal regulated kinase kinases 1 and 2 (MEK1 and MEK2); this results in their activation. Through the stimulation of the Ras–Raf pathway, BCR-ABL increases growth factor-independent cell growth. BCR-ABL also associates with and activates the phosphatidylinositol-3 kinase (PI3K) pathway, suppressing programmed cell death and increasing cell survival. BCR-ABL is associated with components of the focal adhesion(that is, actin, paxillin and focal adhesion kinase, or FAK); the activation of CRKL–FAK–PYK2 leads to a decrease in cell adhesion. BCR-ABL also associates with the Janus kinase and signal transducer and activator of transcription (JAK–STAT) pathway. Finally, BCR-ABL activates pathways that lead to atypical responses to chemotactic factors, which leads to an increase in cell migration. BCR-ABL also associates with survival proteins that interact with the mitochondrial-based BCL2 family. CAS, p130 CRK-associated substrate; GAB2, GRB2-associated binding protein 2; SHIP, SH2-containing inositol-5-phosphatase
Weisberg et al. 7:345, 2007
![Page 31: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/31.jpg)
(Imatinib mesilato)
![Page 32: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/32.jpg)
ITAM (Immunoreceptor tyrosine-based inhibitory motif) : DExxYxxL/I(x)6-
7YxxL/I
TRASDUZIONE DEL SEGNALE DA PARTE DI RECETTORI IMMUNI
![Page 33: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/33.jpg)
ITAM ITIM: I/VxxYxxL/V
FcRIIA FcRIIB
Immunoreceptor tyrosine-based inhibitory motif
![Page 34: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/34.jpg)
TRASDUZIONE DEL SEGNALE DA PARTE DI RECETTORI IMMUNI
![Page 35: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/35.jpg)
attivazione
![Page 36: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/36.jpg)
![Page 37: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/37.jpg)
C-type lectins
![Page 38: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/38.jpg)
ZAP70
Fyn/ LckSyk
Syk
SykSyk
Lyn
Lyn
Lyn/Hck/Fgr
![Page 39: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/39.jpg)
![Page 40: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/40.jpg)
![Page 41: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/41.jpg)
![Page 42: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/42.jpg)
![Page 43: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/43.jpg)
Abl
![Page 44: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/44.jpg)
Lipide fosfatasi
![Page 45: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/45.jpg)
Protein fosfatasi
![Page 46: TIROSIN CHINASI CITOPLASMATICHE](https://reader035.vdocuments.site/reader035/viewer/2022062422/56812f4e550346895d94df95/html5/thumbnails/46.jpg)
YPSYK
SFK
?
SYKYP
ITA
M
ANCHE ALCUNE FAMIGLIE DI INTEGRINE (2 E 3) TRASDUCONO IL SEGNALEMEDIANTE UN MODULO BASATO SU ADATTATORI CON SEQUENZA ITAM E SYK